BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 8, 2019
View Archived Issues
Novel transgenerational mouse model of insulin resistance
Read More
Mycobiome linked to pancreatic cancer
Read More
Dual inhibition of TGF-beta and AXL as novel therapeutic approach in metastatic CRC
Read More
rSIFN-co demonstrates antitumor activity in phase I study in advanced solid tumors
Read More
Phase I results for DNA vaccine MVI-118 in patients with metastatic prostate cancer
Read More
C-75 improves survival of mice with sepsis through blocking TLR/MYD88 signaling in neutrophils
Read More
Enrollment underway in phase I/II study of CTNS-RD-04 stem cell gene therapy for cystinosis
Read More
First cohort subject dosed in phase I study of SCD inhibitor YTX-7739
Read More
NKTR-358 begins new phase Ib studies in psoriasis and atopic dermatitis
Read More
Inhaled AZD-8154 demonstrates superior pharmacokinetics over intravenous administration
Read More
Hawaii Biotech divulges compounds for anthrax
Read More
Biogen patents OGA inhibitors
Read More
H. Lee Moffitt Cancer Center and Research Institute presents YAP1/POU5F1 interaction inhibitors
Read More
Aerie Pharmaceuticals synthesizes new kinase inhibitors
Read More
Genentech patents TRPA1 antagonists
Read More
Dermavant initiates phase IIa study of cerdulatinib gel in vitiligo
Read More
Phase III extension study of VM-202 in diabetic peripheral neuropathy meets primary endpoint
Read More
BARDA contract supports Platelet BioGenesis' development of donor-independent platelets
Read More
Advaxis updates median overall survival data from phase I/II study of ADXS-PSA in metastatic CRPC
Read More
FDA approves Beovu for wet age-related macular degeneration
Read More
Evaluating gepotidacin in the treatment of uncomplicated urinary tract infections: a phase IIa study
Read More
Three win Nobel for hypoxia work
Read More
Bavarian Nordic begins first-in-human study of MVA-BN-WEV for equine encephalitis virus
Read More
ONL Therapeutics advances ONL-1204 into phase I study for retinal detachment
Read More